Tool can ‘smell’ prostate cancer

A tool that “smells” prostate cancer could herald the end of invasive diagnostic procedures, researchers reported yesterday.

Scientists from the University of Liverpool in England say they have reached an important milestone in the development of a urine test that uses a special tool that “smells” cancer.

Working with the University of the West of England’s (UWE Bristol) Urological Institute team at Southmead Hospital and Bristol Royal Infirmary, the team enrolled 155 men for a pilot study. All had been referred to urology clinics.

Of the cohort, 58 were diagnosed with prostate cancer, 24 had bladder cancer and 73 were found to have haematuria without cancer.

Writing in the latest edition of Journal of Breath Research, the team describes how it used a gas chromatography (GC)-sensor system called Odoreader, to identify different patterns of volatile compounds that allow classification of urine samples from patients with urological cancers.

Professor Chris Probert, who developed the Odoreader with Professor Norman Ratcliffe at UWE Bristol, said the test involves inserting urine samples into the device, which are then measured using algorithms developed by the research team.

“There is an urgent need to identify these cancers at an earlier stage when they are more treatable as the earlier a person is diagnosed the better” he said.

“After further sample testing the next step is to take this technology and put it into a user friendly format. With help from industry partners we will be able to further develop the Odoreader, which will enable it to be used where it is needed most; at a patient’s bedside, in a doctor’s surgery, in a clinic or Walk In Centre, providing fast, inexpensive, accurate results.”

Professor Norman Ratcliffe explained how the device works: “The Odoreader has a 30-metre column that enables the compounds in the urine to travel through at different rates, thus breaking the sample into a readable format.

“This is then translated into an algorithm enabling detection of cancer by reading the patterns presented. The positioning of the prostate gland which is very close to the bladder gives the urine profile a different algorithm if the man has cancer.”

Mr Raj Prasad, consultant urologist at Southmead Hospital, North Bristol NHS Trust, said: “If this test succeeds at full medical trial it will revolutionise diagnostics.”

The pilot trial was funded by the Rotary Club in Bristol. The research team is now looking to fund a full clinical trial.

Aggio R, de Lacey Castello B, White P et al. The use of a gas chromatography-sensor system combined with advanced statistical methods, towards the diagnosis of urological malignancies. Journal of Breath Research 11 February 2016; Volume 10, Number 1. [abstract]

, ,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index